J. H. Louw
University of Cape Town
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J. H. Louw.
The Lancet | 1976
R.G. Fiddian-Green; I. N. Marks; S. Bank; J. H. Louw
In a retrospective analysis of 2218 tests of gastric secretion 27% of patients with duodenal ulcers had an abnormal capacity to secrete acid. The abnormality was evident only in patients who had had symptoms for longer than three years, and was greatest in patients who had had symptoms for six to nine years. There was no significant difference between the capacity to secretic acid in patients who had symptoms of duodenal ulcer for less than three years and the capacity to secretic acid in normal controls. The tendency for the capacity to secrete acid to increase with duration of symptoms was also evident in patients with gastric ulcers. The positions in which ulcers were found were closely related to the maximum acid output (M.A.O.), and to the age of patients. The site of recurrent ulcers, after vagotomy and drainage, was also related to the M.A.O. after vagotomy. These influences of ageing and vagotomy on the site of ulcers can be attributed to their antecedent effect on the M.A.O. It is suggested that the capacity to secret acid alone is not responsible for the genesis of peptic ulcers but that it influences the position in which an ulcer may develop under the influence of an unknown ulcerogenic factor.
The Lancet | 1976
R.G. Fiddian-Green; I. N. Marks; S. Bank; J. H. Louw
The relationship between the capacity to secrete acid and the risk of peptic ulcer has been examined prospectively in 114 healthy symptom-free students and retrospectively in 2361 patients with and without ulcers. The risk of ulcer was found to increase as te maximum acid output (M.A.O.) increased, and the risk of recurrent ulceration, after vagotomy and drainage for duodenal ulceration, was found to increase as the postvagotomy M.A.O. increased. The risk of recurrent ulcer, at any postvagotomy M.A.O., was always greater than the risk of ulceration in a healthy individual with an equivalent M.A.O.. The addition of an antrectomy to a vagotomy restored the risk of recurrent ulcer towards that of a healthy individual developing his first ulcer. The therapeutic benefit of adding an antrectomy to a vagotomy could not be attributed solely to its enhancement of the percentage reduction in M.A.O. from 65% to 95%. The major therapeutic effect of an antrectomy seems to be achieved independently of its action on M.A.O.
The Lancet | 1955
J. H. Louw; C.N. Barnard
British Journal of Surgery | 1979
M. S. Elliot; E. J. Immelman; P. Jeffery; S. R. Benatar; M. R. Funston; J. A. Smith; B. J. Shepstone; A. D. Ferguson; P. Jacobs; W. Walker; J. H. Louw
The Lancet | 1963
J. H. Louw
British Journal of Surgery | 1979
M. S. Elliot; E. J. Immelman; P. Jeffery; S. R. Benatar; M. R. Funston; J. A. Smith; P. Jacobs; B. J. Shepstone; A. D. Ferguson; J. H. Louw
British Journal of Surgery | 1973
J. V. Robbs; S. Bank; I. N. Marks; J. H. Louw
British Journal of Surgery | 1979
M. S. Elloit; J. H. Louw
British Journal of Surgery | 1981
M. V. Madden; M. S. Elliot; J. B. C. Botha; J. H. Louw
The Lancet | 1967
S. Bank; I.N. Marks; J. H. Louw; N. Tigler-Wybrandi